Alongside cagrilintide, our metabolic research catalog includes Semaglutide (GLP-1 monoagonist), Tirzepatide (GLP-1/GIP dual agonist), Retatrutide (GLP-1/GIP/glucagon triagonist), AOD-9604 (hGH lipolytic fragment), MOTS-C (mitochondrial metabolic regulator), and 5-Amino-1MQ (NNMT inhibitor)
Recovery in amyotrophic lateral sclerosis
Safe when used under professional care
Wegovy can delay gastric emptying, particularly during treatment initiation, which could theoretically affect the absorption and transit of other orally administered medications
Glutathione reductase then uses NADPH to regenerate two molecules of active GSH from GSSG, completing the antioxidant cycle
Formulated with gentle, plant-based ingredients for daily digestive support